ClinicalThought

Share

Program Content

Activities

  • Updates for HER2 CRC
    My Take on Tucatinib and Trastuzumab for HER2-Positive Metastatic Colorectal Cancer
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 10, 2022

    Expires: August 09, 2023

Faculty

cover img faculity

John Strickler, MD

Assistant Professor
Division of Medical Oncology
Department of Medicine
Duke University
Durham, North Carolina

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Seagen Inc.